Seizure	seizure	O	DISEASE	OTHERS	I
activity	activity	O	O	O	O
with	with	O	O	O	O
imipenem	imipenem	O	O	OTHERS	I
therapy	therapy	O	O	O	O
:	:	O	O	O	O
incidence	incidence	O	O	O	O
and	and	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
elderly	elderly	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
either	either	O	O	O	O
cerebral	cerebral	O	O	OTHERS	I
vascular	vascular	O	O	OTHERS	I
accident	accident	O	O	OTHERS	I
(	(	O	O	O	O
CVA	cva	O	O	OTHERS	I
)	)	O	O	O	O
or	or	O	O	O	O
head	head	O	O	OTHERS	I
trauma	trauma	O	O	OTHERS	I
and	and	O	O	O	O
no	no	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
renal	renal	O	O	OTHERS	I
disease	disease	O	O	OTHERS	I
developed	developed	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
while	while	O	O	O	O
receiving	receiving	O	O	O	O
maximum	maximum	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
imipenem/cilastatin	imipenem/cilastatin	O	O	O	O
.	.	O	O	O	O

Neither	neither	O	O	O	O
patient	patient	O	O	O	O
had	had	O	O	O	O
reported	reported	O	O	O	O
previous	previous	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
or	or	O	O	O	O
seizure-like	seizure-like	O	O	O	O
activity	activity	O	O	O	O
nor	nor	O	O	O	O
was	was	O	O	O	O
receiving	receiving	O	O	O	O
anticonvulsant	anticonvulsant	O	O	O	O
agents	agents	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
were	were	O	O	O	O
controlled	controlled	O	O	O	O
with	with	O	O	O	O
therapeutic	therapeutic	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
phenytoin	phenytoin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Both	both	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
received	received	O	O	O	O
maximum	maximum	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
other	other	O	O	O	O
beta-lactam	beta-lactam	O	O	O	O
antibiotics	antibiotics	O	O	O	O
without	without	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
activity	activity	O	O	O	O
.	.	O	O	O	O

